JP2016532457A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016532457A5 JP2016532457A5 JP2016547976A JP2016547976A JP2016532457A5 JP 2016532457 A5 JP2016532457 A5 JP 2016532457A5 JP 2016547976 A JP2016547976 A JP 2016547976A JP 2016547976 A JP2016547976 A JP 2016547976A JP 2016532457 A5 JP2016532457 A5 JP 2016532457A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell culture
- cell
- interest
- metabolic shift
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020024484A JP6967620B2 (ja) | 2013-10-11 | 2020-02-17 | 代謝が最適化された細胞培養 |
| JP2021173755A JP7377243B2 (ja) | 2013-10-11 | 2021-10-25 | 代謝が最適化された細胞培養 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361889815P | 2013-10-11 | 2013-10-11 | |
| US61/889,815 | 2013-10-11 | ||
| PCT/US2014/059993 WO2015054554A1 (en) | 2013-10-11 | 2014-10-10 | Metabolically optimized cell culture |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020024484A Division JP6967620B2 (ja) | 2013-10-11 | 2020-02-17 | 代謝が最適化された細胞培養 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016532457A JP2016532457A (ja) | 2016-10-20 |
| JP2016532457A5 true JP2016532457A5 (https=) | 2017-11-09 |
| JP6663854B2 JP6663854B2 (ja) | 2020-03-13 |
Family
ID=52813657
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016547976A Active JP6663854B2 (ja) | 2013-10-11 | 2014-10-10 | 代謝が最適化された細胞培養 |
| JP2020024484A Active JP6967620B2 (ja) | 2013-10-11 | 2020-02-17 | 代謝が最適化された細胞培養 |
| JP2021173755A Active JP7377243B2 (ja) | 2013-10-11 | 2021-10-25 | 代謝が最適化された細胞培養 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020024484A Active JP6967620B2 (ja) | 2013-10-11 | 2020-02-17 | 代謝が最適化された細胞培養 |
| JP2021173755A Active JP7377243B2 (ja) | 2013-10-11 | 2021-10-25 | 代謝が最適化された細胞培養 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20160244725A1 (https=) |
| EP (3) | EP3351620B1 (https=) |
| JP (3) | JP6663854B2 (https=) |
| KR (4) | KR102243980B1 (https=) |
| CN (2) | CN105637085A (https=) |
| AU (2) | AU2014331776B2 (https=) |
| CA (1) | CA2926049C (https=) |
| DK (3) | DK3351620T3 (https=) |
| EA (2) | EA033783B1 (https=) |
| ES (2) | ES2833471T3 (https=) |
| HU (2) | HUE039551T2 (https=) |
| IL (2) | IL244511A0 (https=) |
| MX (2) | MX384960B (https=) |
| PL (2) | PL3351620T3 (https=) |
| SG (2) | SG10201800772TA (https=) |
| WO (1) | WO2015054554A1 (https=) |
| ZA (1) | ZA201601550B (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11390663B2 (en) | 2013-10-11 | 2022-07-19 | Regeneron Pharmaceuticals, Inc. | Metabolically optimized cell culture |
| US20160244726A1 (en) * | 2013-10-11 | 2016-08-25 | Regeneron Pharmaceuticals, Inc. | Metabolically optimized cell culture |
| KR102243980B1 (ko) | 2013-10-11 | 2021-04-26 | 리제너론 파마슈티칼스 인코포레이티드 | 대사적으로 최적화된 세포 배양 |
| JP7260018B2 (ja) * | 2017-03-31 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7260011B2 (ja) * | 2017-03-31 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7260020B2 (ja) * | 2017-03-31 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7260012B2 (ja) * | 2017-04-27 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7260013B2 (ja) * | 2017-04-27 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7310945B2 (ja) * | 2017-04-27 | 2023-07-19 | 株式会社三洋物産 | 遊技機 |
| JP7260009B2 (ja) * | 2017-04-27 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7310947B2 (ja) * | 2017-04-27 | 2023-07-19 | 株式会社三洋物産 | 遊技機 |
| JP7272480B2 (ja) * | 2017-04-27 | 2023-05-12 | 株式会社三洋物産 | 遊技機 |
| JP7310952B2 (ja) * | 2017-04-27 | 2023-07-19 | 株式会社三洋物産 | 遊技機 |
| JP7260021B2 (ja) * | 2017-04-27 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| US11609120B2 (en) | 2017-10-06 | 2023-03-21 | Lonza Ltd | Automated control of cell culture using Raman spectroscopy |
| EP4039786A1 (en) | 2017-10-16 | 2022-08-10 | Regeneron Pharmaceuticals, Inc. | Perfusion bioreactor and related methods of use |
| US20200385673A1 (en) * | 2017-11-30 | 2020-12-10 | Hoffmann-La Roche Inc. | Process for culturing mammalian cells |
| JP2021519073A (ja) * | 2018-03-29 | 2021-08-10 | ジェネンテック， インコーポレイテッド | 哺乳動物細胞におけるラクトジェニック活性の制御 |
| GB201810772D0 (en) | 2018-06-29 | 2018-08-15 | Ge Healthcare Bio Sciences Ab | Method in bioprocess purification system |
| JP7231355B2 (ja) * | 2018-08-22 | 2023-03-01 | 日機装株式会社 | 細胞培養方法および細胞培養装置 |
| CN119264211A (zh) | 2018-08-27 | 2025-01-07 | 瑞泽恩制药公司 | 拉曼光谱在下游纯化中的应用 |
| WO2020084034A1 (en) | 2018-10-26 | 2020-04-30 | F. Hoffmann-La Roche Ag | Multispecific antibody screening method using recombinase mediated cassette exchange |
| JP2020151560A (ja) * | 2020-06-24 | 2020-09-24 | 株式会社三洋物産 | 遊技機 |
| JP2020151559A (ja) * | 2020-06-24 | 2020-09-24 | 株式会社三洋物産 | 遊技機 |
| EP3985097A1 (en) * | 2020-10-14 | 2022-04-20 | Sartorius Stedim Biotech GmbH | A method and system for configuring and/or setup of a downstream process for processing a biomass |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| KR970029803A (ko) | 1995-11-03 | 1997-06-26 | 김광호 | 반도체 메모리장치의 프리차지 회로 |
| US6165741A (en) | 1997-05-30 | 2000-12-26 | The Trustees Of The University Of Pennsylvania | Method for rapid detection of bacterial growth in cultures |
| US5972650A (en) | 1997-06-26 | 1999-10-26 | Brigham And Women's Hospital | Tetracycline repressor regulated mammalian cell transcription and viral replication switch |
| US6919183B2 (en) | 2001-01-16 | 2005-07-19 | Regeneron Pharmaceuticals, Inc. | Isolating cells expressing secreted proteins |
| US6953692B2 (en) * | 2001-12-18 | 2005-10-11 | Bayer Pharmaceuticals Corporation | Device and method for seed-train expansion of mammalian cells |
| CA2417689C (en) | 2002-03-05 | 2006-05-09 | F. Hoffmann-La Roche Ag | Improved methods for growing mammalian cells in vitro |
| US7039770B1 (en) | 2002-03-05 | 2006-05-02 | Juniper Networks, Inc. | Low latency request dispatcher |
| US8673589B2 (en) | 2002-05-29 | 2014-03-18 | Regeneron Pharmaceuticals, Inc. | Inducible eukaryotic expression system |
| EP1623019B2 (en) | 2003-05-15 | 2017-01-25 | Wyeth LLC | Restricted glucose feed for animal cell culture |
| US7531327B2 (en) * | 2004-07-23 | 2009-05-12 | Immunomedics, Inc. | Methods and compositions for increasing longevity and protein yield from a cell culture |
| US7335491B2 (en) | 2004-08-27 | 2008-02-26 | Wyeth Research Ireland Limited | Production of anti-abeta |
| TWI364458B (en) * | 2004-08-27 | 2012-05-21 | Wyeth Res Ireland Ltd | Production of tnfr-lg |
| CN101300342A (zh) * | 2005-11-02 | 2008-11-05 | 惠氏公司 | 用于使哺乳动物细胞具备适应性的方法 |
| CA2631184A1 (en) | 2005-11-28 | 2007-05-31 | Genmab A/S | Recombinant monovalent antibodies and methods for production thereof |
| US7575890B2 (en) | 2006-01-18 | 2009-08-18 | Oxygen Enterprises, Ltd. | Method for rapid detection and evaluation of cultured cell growth |
| ES2541546T3 (es) | 2006-11-03 | 2015-07-21 | Wyeth Llc | Sustancias que inhiben la glucólisis en cultivo celular |
| EP2150617B1 (en) | 2007-06-04 | 2014-10-22 | Regeneron Pharmaceuticals, Inc. | Enhanced expression and stability regions |
| ES2657055T3 (es) | 2007-08-09 | 2018-03-01 | Wyeth Llc | Uso de perfusión para mejorar la producción de un cultivo de células alimentado por lotes en biorreactores |
| US20090325287A1 (en) * | 2008-06-13 | 2009-12-31 | Haimanti Dorai | Methods for Obtaining High Viable Cell Density in Mammalian Cell Culture |
| US8470552B2 (en) | 2009-10-12 | 2013-06-25 | Keck Graduate Institute | Strategy to reduce lactic acid production and control PH in animal cell culture |
| CA2797356C (en) * | 2010-04-26 | 2020-12-29 | Novartis Ag | Improved cell culture medium |
| CA2800728C (en) * | 2010-05-28 | 2020-10-27 | Genentech, Inc. | Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase |
| TWI637057B (zh) | 2012-11-09 | 2018-10-01 | 拜爾沙納有限公司 | 具交替生物反應器用途之不連續進料批次製程 |
| US20150353542A1 (en) * | 2013-01-14 | 2015-12-10 | Amgen Inc. | Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture |
| KR102243980B1 (ko) | 2013-10-11 | 2021-04-26 | 리제너론 파마슈티칼스 인코포레이티드 | 대사적으로 최적화된 세포 배양 |
-
2014
- 2014-10-10 KR KR1020167009163A patent/KR102243980B1/ko active Active
- 2014-10-10 AU AU2014331776A patent/AU2014331776B2/en active Active
- 2014-10-10 ES ES18161278T patent/ES2833471T3/es active Active
- 2014-10-10 PL PL18161278T patent/PL3351620T3/pl unknown
- 2014-10-10 DK DK18161278.9T patent/DK3351620T3/da active
- 2014-10-10 KR KR1020217011547A patent/KR102358807B1/ko active Active
- 2014-10-10 KR KR1020237008467A patent/KR102610425B1/ko active Active
- 2014-10-10 HU HUE14851841A patent/HUE039551T2/hu unknown
- 2014-10-10 EP EP18161278.9A patent/EP3351620B1/en not_active Revoked
- 2014-10-10 ES ES14851841.8T patent/ES2678945T3/es active Active
- 2014-10-10 SG SG10201800772TA patent/SG10201800772TA/en unknown
- 2014-10-10 MX MX2020011334A patent/MX384960B/es unknown
- 2014-10-10 DK DK14851841.8T patent/DK3055409T3/en active
- 2014-10-10 HU HUE18161278A patent/HUE051049T2/hu unknown
- 2014-10-10 DK DK20193898.2T patent/DK3812453T3/da active
- 2014-10-10 CA CA2926049A patent/CA2926049C/en active Active
- 2014-10-10 US US15/028,521 patent/US20160244725A1/en not_active Abandoned
- 2014-10-10 WO PCT/US2014/059993 patent/WO2015054554A1/en not_active Ceased
- 2014-10-10 PL PL14851841T patent/PL3055409T3/pl unknown
- 2014-10-10 EP EP20193898.2A patent/EP3812453B1/en active Active
- 2014-10-10 SG SG11201601681QA patent/SG11201601681QA/en unknown
- 2014-10-10 CN CN201480055499.4A patent/CN105637085A/zh active Pending
- 2014-10-10 EP EP14851841.8A patent/EP3055409B1/en not_active Revoked
- 2014-10-10 JP JP2016547976A patent/JP6663854B2/ja active Active
- 2014-10-10 KR KR1020227003381A patent/KR102510238B1/ko active Active
- 2014-10-10 MX MX2016004564A patent/MX376623B/es active IP Right Grant
- 2014-10-10 CN CN202210497778.2A patent/CN114717196A/zh active Pending
- 2014-10-10 EA EA201690600A patent/EA033783B1/ru active IP Right Revival
- 2014-10-10 EA EA201991976A patent/EA201991976A1/ru unknown
-
2016
- 2016-03-04 ZA ZA2016/01550A patent/ZA201601550B/en unknown
- 2016-03-08 IL IL244511A patent/IL244511A0/en unknown
-
2018
- 2018-11-06 IL IL262833A patent/IL262833A/en unknown
-
2020
- 2020-02-17 JP JP2020024484A patent/JP6967620B2/ja active Active
- 2020-08-04 US US16/984,531 patent/US20210087535A1/en active Pending
-
2021
- 2021-01-14 AU AU2021200193A patent/AU2021200193B2/en active Active
- 2021-10-25 JP JP2021173755A patent/JP7377243B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016532457A5 (https=) | ||
| Zeltz et al. | α11β1 integrin is induced in a subset of cancer-associated fibroblasts in desmoplastic tumor stroma and mediates in vitro cell migration | |
| Jabalee et al. | The role of extracellular vesicles in cancer: cargo, function, and therapeutic implications | |
| Rankin et al. | The receptor tyrosine kinase AXL in cancer progression | |
| Roato et al. | Cancer stem cells, bone and tumor microenvironment: key players in bone metastases | |
| Panou et al. | Agnoprotein is an essential egress factor during BK polyomavirus infection | |
| HRP20220081T1 (hr) | Bcma i cd3 bispecifična t stanica koja uključuje konstrukte protutijela | |
| JP2018514204A5 (https=) | ||
| IL292650B1 (en) | COSTIMULATORY CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING IL13Ra2 | |
| JP2016196468A5 (https=) | ||
| MX383868B (es) | Anticuerpos contra cd73 y sus usos. | |
| GB2549632A8 (en) | Fusion protein comprising three binding domains to 5T4 and CD3 | |
| JP2014534207A5 (https=) | ||
| RU2018146533A (ru) | Антитела к cd40 и пути их применения | |
| FI3390442T3 (fi) | Anti-C5-vasta-aineita ja käyttömenetelmiä | |
| Gingrich et al. | Characterization and potential applications of dog natural killer cells in cancer immunotherapy | |
| Wang et al. | Genome-wide identification and expression analysis of MAPK gene family in lettuce (Lactuca sativa L.) and functional analysis of LsMAPK4 in high-temperature-induced bolting | |
| Schmidt et al. | A bivalent trans-amplifying RNA vaccine candidate induces potent chikungunya and ross river virus specific immune responses | |
| EP2534099A4 (en) | SYSTEM AND METHOD FOR PRODUCING RENEWABLE RESOURCES, SUCH AS HYDROGEN BY MICROBIAL ELECTROLYSIS, FERMENTATION AND / OR PHOTOSYNTHESIS | |
| Piñeiro-Ramil et al. | Generation of mesenchymal cell lines derived from aged donors | |
| Chalenko et al. | Natural isoforms of Listeria monocytogenes virulence factor Inlb differ in c-Met binding efficiency and differently affect uptake and survival Listeria in macrophage | |
| JP2013531967A5 (https=) | ||
| FI3063287T3 (fi) | Monensiinin käyttö rekombinanttiproteiinien glykosylaation säätelyyn | |
| Ibrahim et al. | Bioinformatics Meets Virology: The European Virus Bioinformatics Center’s Second Annual Meeting | |
| Iikawa et al. | Intrinsic oncogenic function of intracellular Connexin26 protein in head and neck squamous cell carcinoma cells |